Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.

Andersen DC, Kortesidis A, Zannettino AC, Kratchmarova I, Chen L, Jensen ON, Teisner B, Gronthos S, Jensen CH, Kassem M.

Mol Cells. 2011 Aug;32(2):133-42. doi: 10.1007/s10059-011-2277-7. Epub 2011 May 23.

2.
3.

Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.

Miura Y, Miura M, Gronthos S, Allen MR, Cao C, Uveges TE, Bi Y, Ehirchiou D, Kortesidis A, Shi S, Zhang L.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14022-7. Epub 2005 Sep 19.

4.

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

Zannettino AC, Farrugia AN, Kortesidis A, Manavis J, To LB, Martin SK, Diamond P, Tamamura H, Lapidot T, Fujii N, Gronthos S.

Cancer Res. 2005 Mar 1;65(5):1700-9.

5.

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S.

Blood. 2005 May 15;105(10):3793-801. Epub 2005 Jan 27.

PMID:
15677562
6.

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow.

Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ.

J Cell Sci. 2003 May 1;116(Pt 9):1827-35.

Supplemental Content

Loading ...
Support Center